Use of psychostimulants in medically ill patients with neurological disease and major depression.
The effective therapeutic response to dextroamphetamine and methylphenidate by five depressed patients with neurological disease is described. In four of these patients tricyclic antidepressants had to be discontinued due to the concomitant deterioration of their cognitive functions, and in one case they were not used due to cardiovascular complications. There was a rapid remission of depressive symptomatology with no adverse side effects, consistent with the findings of other investigators. The possible association of right hemisphere strokes and depression is also discussed. Further evaluation of the therapeutic role of psychostimulants in the treatment of depressed patients with structurally-compromised brain function is recommended.
D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D003913:Dextroamphetamine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000150:complications*
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D008774:Methylphenidate; D003913:Dextroamphetamine